Skip to main content
Back to feed
HealthConfirmedMediumDeveloping
7.3

GSK initiates £1.9bn cost-cutting program and R&D consolidation in UK

GSK is implementing a £1.9bn restructuring plan involving significant job cuts to fund a £400m investment in UK life sciences. The strategy includes relocating over 1,000 scientists to a new Cambridge R&D facility to accelerate drug development timelines under new leadership.

Guardian Worldabout 8 hours agoGBCredibility 37%View source

Score Breakdown

Mosaic Score7.3
Confidence0.9
Significance0.5
Source credibility0.4

Intelligence Tags

#pharmaceuticals#restructuring#r&d#gsk#biotech

Locations

Cambridge

Entities

country
Source

Related signals

8 found